In conjunction with our data, this evidence suggests that high FABP7 expression levels, particularly in primary GBM tissues, may not consistently result in more favorable intra- and extracellular environments for malignant tumor cell survival and maintenance nor lead to a worse prognosis compared to tumors with lower FABP7 expression levels. This evidence concerns the gene FABP7 and glioblastoma.